Advanced Proteome Therapeutics Corporation
APTCF · OTC
4/30/2023 | 1/31/2023 | 10/31/2022 | 7/31/2022 | |
|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Cost of Goods Sold | $0 | $1 | $1 | $1 |
| Gross Profit | -$0 | -$1 | -$1 | -$1 |
| % Margin | – | – | – | – |
| R&D Expenses | $85 | $167 | $176 | $167 |
| G&A Expenses | $38 | $80 | $47 | -$427 |
| SG&A Expenses | $53 | $111 | $78 | $91 |
| Sales & Mktg Exp. | $15 | $31 | $31 | $0 |
| Other Operating Expenses | $12 | $9 | $3 | $0 |
| Operating Expenses | $150 | $287 | $256 | $258 |
| Operating Income | -$150 | -$287 | -$256 | -$258 |
| % Margin | – | – | – | – |
| Other Income/Exp. Net | -$1,352 | -$46 | -$5 | $141 |
| Pre-Tax Income | -$1,502 | -$333 | -$259 | -$117 |
| Tax Expense | $0 | $0 | $0 | $0 |
| Net Income | -$1,478 | -$278 | -$210 | -$76 |
| % Margin | – | – | – | – |
| EPS | -0.036 | -0.007 | -0.005 | -0.002 |
| % Growth | -426.1% | -30.2% | -178.9% | – |
| EPS Diluted | -0.036 | -0.007 | -0.005 | -0.002 |
| Weighted Avg Shares Out | 40,711 | 40,308 | 39,677 | 39,677 |
| Weighted Avg Shares Out Dil | 40,711 | 40,308 | 39,677 | 39,677 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $1 | $1 |
| Interest Expense | $4 | $12 | $13 | $7 |
| Depreciation & Amortization | $0 | $1 | $1 | $1 |
| EBITDA | -$1,496 | -$324 | -$244 | -$109 |
| % Margin | – | – | – | – |